Long-term, Non-interventional Study of Recipients of Yescarta® for Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Primary Mediastinal Large B-Cell Lymphoma, and Follicular Lymphoma

06/12/2019
31/07/2024
EU PAS number:
EUPAS32539
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

KT-EU-471-0117-appendix-16.1.1-protocol amendment 3_f-redact_reducedsize

English (4.76 MB - PDF) View document
Updated protocol

KT-EU-471-0117-appendix-16.1.1-protocol amendment 5_f-redact_reducedsize

First published: 22/02/2024
English (9.98 MB - PDF) View document
Study results
Study report
Other information